Why Does My Patient Have Leukocytosis?

Hematology/Oncology Clinics of North America

Volumn 26, Issue 2, 2012, Pages 303-319

  Cerny, Jan ^a,b   Rosmarin, Alan G ^a,b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UMASS MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Diagnostic evaluation; Leukemia; Leukocytosis; Lymphocytosis; Myeloproliferative neoplasm; Neutrophilia

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; CYTOTOXIC AGENT; IMATINIB; LITHIUM; MEPOLIZUMAB; RECOMBINANT CYTOKINE; STEROID;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE MYELOMONOCYTIC LEUKEMIA; AUTOIMMUNE THROMBOCYTOPENIA; BABESIOSIS; BACTERIAL INFECTION; BARTONELLOSIS; BLOOD CELL COUNT; BONE MARROW METASTASIS; BONE MARROW SUPPRESSION; BRUCELLOSIS; CELL MATURATION; CELL SURVIVAL; CHRONIC HEPATITIS; CHRONIC INFLAMMATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CIGARETTE SMOKING; CLOSTRIDIUM DIFFICILE INFECTION; CONGENITAL DISORDER OF GLYCOSYLATION TYPE 2C; CYTOMEGALOVIRUS INFECTION; DOWN SYNDROME; DRUG HYPERSENSITIVITY; EHRLICHIOSIS; ENDOCARDITIS; ENTERITIS; EOSINOPHILIA; EPSTEIN BARR VIRUS INFECTION; ERYTHROCYTE; FIBROSIS; GIANT CELL ARTERITIS; GRANULOCYTE; GRANULOMATOSIS; HEMATOPOIETIC STEM CELL; HEMOLYTIC ANEMIA; HUMAN; HYPEREOSINOPHILIC SYNDROME; JUVENILE RHEUMATOID ARTHRITIS; KIDNEY TUMOR; LEISHMANIASIS; LEUKEMIA; LEUKOCYTE; LEUKOCYTE ADHESION DEFICIENCY; LEUKOCYTE COUNT; LEUKOCYTOSIS; LEUKOPENIA; LUNG TUMOR; LYMPHOCYTE; LYMPHOCYTOSIS; MEGAKARYOCYTE; MONOCYTE; MONOCYTOSIS; MYCOSIS; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL; NEUTROPHILIA; NONHODGKIN LYMPHOMA; PERTUSSIS; POLYCYTHEMIA VERA; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RICKETTSIOSIS; SARCOIDOSIS; SERUM SICKNESS; SPINAL CORD ATROPHY; SPLENECTOMY; STAPHYLOCOCCUS INFECTION; SYPHILIS; THROMBOCYTE; THROMBOCYTOSIS; TONGUE TUMOR; TUBERCULOSIS; TULAREMIA; TYPHOID FEVER; UROGENITAL TRACT TUMOR; URTICARIA; VASCULITIS; VIRUS HEPATITIS; VIRUS INFECTION;

CELL DIFFERENTIATION; HUMANS; LEUKOCYTES; LEUKOCYTOSIS;

EID: 84859042600     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2012.01.001     Document Type: Review

References (40)

1. Turgeon M.L. Clinical hematology: theory and procedures 2004, Lippincott Williams & Wilkins, Philadelphia. 4th edition.
2. Novotny J.R., Müller-Beißenhirtz H., Herget-Rosenthal S., et al. Grading of symptoms in hyperleukocytic leukaemia: a clinical model for the role of different blast types and promyelocytes in the development of leukostasis syndrome. Eur J Haematol 2005, 74:501-510.
3. Novotny J.R., Nückel H., Dührsen U. Correlation between expression of CD56/NCAM and severe leukostasis in hyperleukocytic acute myelomonocytic leukaemia. Eur J Haematol 2006, 76:299-308.
4. Steel J.M., Steel C.M., Johnstone F.D. Leukocytosis induced by exercise. Br Med J (Clin Res Ed) 1987, 295:1135-1136.
5. Darko D.F., Rose J., Gillin J.C., et al. Neutrophilia and lymphopenia in major mood disorders. Psychiatry Res 1988, 25:243-251.
6. Green S.M., Vowels J., Waterman B., et al. Leukocytosis: a new look at an old marker for acute myocardial infarction. Acad Emerg Med 1996, 3:1034-1041.
7. Dale D.C., Fauci A.S., Guerry D.I., et al. Comparison of agents producing a neutrophilic leukocytosis in man. Hydrocortisone, prednisone, endotoxin, and etiocholanolone. J Clin Invest 1975, 56:808-813.
8. Lapierre G., Stewart R.B. Lithium carbonate and leukocytosis. Am J Hosp Pharm 1980, 37:1525-1528.
9. Dimitrov S., Lange T., Born J. Selective mobilization of cytotoxic leukocytes by epinephrine. J Immunol 2010, 184:503-511.
10. Sato N., Sawada K., Takahashi T.A., et al. A time course study for optimal harvest of peripheral blood progenitor cells by granulocyte colony-stimulating factor in healthy volunteers. Exp Hematol 1994, 22:973-978.
11. Matsunaga T., Sakamaki S., Kohgo Y., et al. Recombinant human granulocyte colony-stimulating factor can mobilize sufficient amounts of peripheral blood stem cells in healthy volunteers for allogeneic transplantation. Bone Marrow Transplant 1993, 11:103-108.
12. Laterveer L., Lindley I.J., Hamilton M.S., et al. Interleukin-8 induces rapid mobilization of hematopoietic stem cells with radioprotective capacity and long-term myelolymphoid repopulating ability. Blood 1995, 85:2269-2275.
13. Bensinger W., DiPersio J.F., McCarty J.M. Improving stem cell mobilization strategies: future directions. Bone Marrow Transplant 2009, 43:181-195.
14. Papayannopoulou T. Current mechanistic scenarios in hematopoietic stem/progenitor cell mobilization. Blood 2004, 103:1580-1585.
15. Granger J.M., Kontoyiannis D.P. Etiology and outcome of extreme leukocytosis in 758 nonhematologic cancer patients: a retrospective, single-institution study. Cancer 2009, 115:3919-3923.
16. Sharda D.C., Lubani M. A study of brucellosis in childhood. Clin Pediatr (Phila) 1986, 25:492-495.
17. Wood T.A., Frenkel E.P. The atypical lymphocyte. Am J Med 1967, 42:923-936.
18. Tsaparas Y.F., Brigden M.L., Mathias R., et al. Proportion positive for Epstein-Barr virus, cytomegalovirus, human herpesvirus 6, Toxoplasma, and human immunodeficiency virus types 1 and 2 in heterophile-negative patients with an absolute lymphocytosis or an instrument-generated atypical lymphocyte flag. Arch Pathol Lab Med 2000, 124:1324-1330.
19. Abramson N., Melton B. Leukocytosis: basics of clinical assessment. Am Fam Physician 2000, 62:2053-2060.
20. Hillman R.S., Ault K.A., Rinder H.M., et al. Hematology in clinical practice: a guide to diagnosis and management 2005, McGraw-Hill, New York. 4th edition.
21. Plo I., Zhang Y., Le Couedic J.P., et al. An activating mutation in the CSF3R gene induces a hereditary chronic neutrophilia. J Exp Med 2009, 206:1701-1707.
22. Weir A.B., Lewis J.B., Arteta-Bulos R. Chronic idiopathic neutrophilia: experience and recommendations. South Med J 2011, 104:499-504.
23. Shultz L.D., Lyons B.L., Burzenski L.M., et al. Mutations at the mouse ichthyosis locus are within the lamin B receptor gene: a single gene model for human Pelger-Huët anomaly. Hum Mol Genet 2003, 12:61-69.
24. Shetty V.T., Mundle S.D., Raza A. Pseudo Pelger-Huët anomaly in myelodysplastic syndrome: hyposegmented or apoptotic neutrophil?. Blood 2001, 98:1273-1275.
25. Wang E., Boswell E., Siddiqi I., et al. Pseudo-Pelger-Huët anomaly induced by medications. Am J Clin Pathol 2011, 135:291-303.
26. Mundschau G., Gurbuxani S., Gamis A.S., et al. Mutagenesis of GATA1 is an initiating event in Down syndrome leukemogenesis. Blood 2003, 101:4298-4300.
27. Alizadeh P., Rahbarimanesh A.A., Bahram M.G., et al. Leukocyte adhesion deficiency type 1 presenting as leukemoid reaction. Indian J Pediatr 2007, 74:1121-1123.
28. Hoffman H.M., Wright F.A., Broide D.H., et al. Identification of a locus on chromosome 1q44 for familial cold urticaria. Am J Hum Genet 2000, 66:1693-1698.
29. Grimwade D., Hills R.K., Moorman A.V., et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010, 116:354-365.
30. Sanz M.A., Grimwade D., Tallman M.S., et al. Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood 2009, 113:1875-1891.
31. Sanz M.A., Lo-Coco F. Modern approaches to treating acute promyelocytic leukemia. J Clin Oncol 2011, 29:495-503.
32. Druker B.J., Guilhot F., O'Brien S.G., et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006, 355:2408-2417.
33. Kantarjian H., Shah N.P., Hochhaus A., et al. Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia. N Engl J Med 2010, 362:2260-2270.
34. Saglio G., Kim D.W., Issaragrisil S., et al. Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia. N Engl J Med 2010, 362:2251-2259.
35. Gilbert H.S. The spectrum of myeloproliferative disorders. Med Clin North Am 1973, 57:355-393.
36. Wang S.A., Galili N., Cerny J., et al. Chronic myelomonocytic leukemia evolving from preexisting myelodysplasia shares many features with de novo disease. Am J Clin Pathol 2006, 126:789-797.
37. Tefferi A., Gilliland D.G. JAK2 in myeloproliferative disorders is not just another kinase. Cell Cycle 2005, 4:4053-4056.
38. Vakil E., Tefferi A. BCR-ABL1-negative myeloproliferative neoplasms: a review of molecular biology, diagnosis, and treatment. Clin Lymphoma Myeloma Leuk 2011, 11(Suppl 1):S37-S45.
39. Cools J., DeAngelo D.J., Gotlib J., et al. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med 2003, 348:1201-1214.
40. Rothenberg M.E., Klion A.D., Roufosse F.E. Treatment of patients with the hypereosinophilic syndrome with mepolizumab. N Engl J Med 2008, 358:2530.